RT Journal Article
SR Electronic
T1 Understanding non-adherence to tuberculosis medications in India using urine drug metabolite testing: a cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.12.21249665
DO 10.1101/2021.01.12.21249665
A1 Subbaraman, Ramnath
A1 Thomas, Beena E.
A1 Kumar, J. Vignesh
A1 Thiruvengadam, Kannan
A1 Khandewale, Amit
A1 Kokila, S.
A1 Lubeck-Schricker, Maya
A1 Kumar, M. Ranjith
A1 Gaurkhede, Gunjan Rahul
A1 Walgude, Apurva Shashikant
A1 Mercy, J. Hephzibah
A1 Kumbhar, Jagannath Dattatraya
A1 Eliasziw, Misha
A1 Mayer, Kenneth H.
A1 Haberer, Jessica E.
YR 2021
UL http://medrxiv.org/content/early/2021/01/15/2021.01.12.21249665.abstract
AB Background Suboptimal adherence to tuberculosis (TB) treatment is associated with increased disease recurrence and death. Little research has been conducted in India to understand TB medication non-adherence.Methods We enrolled adult drug-susceptible TB patients, about half of whom were people living with HIV (PLHIV), in Chennai, Vellore, and Mumbai. We conducted a single unannounced home visit to administer a survey assessing reasons for non-adherence and collect a urine sample that was tested for isoniazid content. We described patient-reported reasons for non-adherence and identified factors associated with non-adherence (negative urine test) using multivariable logistic regression. We also assessed the association between non-adherence and unfavorable treatment outcomes.Results Of 650 patients in the cohort, 77 (11.8%) had a negative urine test result. Non-adherence was independently associated with daily wage labor (aOR 3.1, CI: 1.3—7.7), smear-positive pulmonary disease (aOR 2.1, CI: 1.1—4.1), alcohol use (aOR 2.3, CI: 1.1—4.8), and spending 60 minutes or more picking up medication refills (aOR 9.1, CI: 1.8—45.4). PLHIV reported greater barriers to picking up medications than non-PLHIV. Among 167 patients who reported missing doses, common reasons reported included traveling away from home, forgetting, feeling depressed, and running out of pills. The odds of non-adherence was 3.8 (CI: 2.1—6.9) times higher among patients with unfavorable treatment outcomes compared to those with favorable outcomes.Conclusion Addressing structural and psychosocial barriers will be critical to improve TB treatment adherence in India. Urine isoniazid testing may help identify non-adherent patients to facilitate early intervention during treatment.Key points We evaluated adherence to tuberculosis medications in 650 Indian patients by conducting urine isoniazid tests collected during unannounced home visits. Structural barriers to collecting medication refills and psychosocial barriers emerged as the most important factors contributing to medication non-adherence.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was primarily supported by grants from the Bill and Melinda Gates Foundation [grant number OPP1154670] to BET and [grant number OPP1154665] to RS. This work was also supported by a Harvard Catalyst KL2/Catalyst Medical Investigator Training Award [grant number KL2 TR001100] to RS, the Harvard Center for AIDS Research [grant number 5P30AI060354-13] to RS, and a Doris Duke Clinical Scientist Development Award [grant number 2018095] to RS.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by ethics committees at the National Institute for Research in TB (NIRT, Chennai, India), Brigham and Womens Hospital (Boston, USA), and Tufts University (Boston, USA).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRequests for the de-identified dataset can be made by contacting Dr. Beena Thomas (beenathomas@nirt.res.in), although access to these data may be limited by NIRT/Indian Council of Medical Research policies.